Cargando…

The Molecular Basis for Remyelination Failure in Multiple Sclerosis

Myelin sheaths in the central nervous system (CNS) insulate axons and thereby allow saltatory nerve conduction, which is a prerequisite for complex brain function. Multiple sclerosis (MS), the most common inflammatory autoimmune disease of the CNS, leads to the destruction of myelin sheaths and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruchot, Joel, Weyers, Vivien, Göttle, Peter, Förster, Moritz, Hartung, Hans-Peter, Küry, Patrick, Kremer, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721708/ https://www.ncbi.nlm.nih.gov/pubmed/31382620 http://dx.doi.org/10.3390/cells8080825

Ejemplares similares

An unmet clinical need: roads to remyelination in MS
por: Göttle, Peter, et al.
Publicado: (2019)

Siponimod Modulates the Reaction of Microglial Cells to Pro-Inflammatory Stimulation
por: Gruchot, Joel, et al.
Publicado: (2022)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Neurological manifestations of severe acute respiratory syndrome coronavirus 2—a controversy ‘gone viral’
por: Förster, Moritz, et al.
Publicado: (2020)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?
por: Göttle, Peter, et al.
Publicado: (2015)

Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models
por: Dietrich, Michael, et al.
Publicado: (2022)

Teriflunomide promotes oligodendroglial differentiation and myelination
por: Göttle, Peter, et al.
Publicado: (2018)

Nitrosative Stress Molecules in Multiple Sclerosis: A Meta-Analysis
por: Förster, Moritz, et al.
Publicado: (2021)

Neural Cell Responses Upon Exposure to Human Endogenous Retroviruses
por: Gruchot, Joel, et al.
Publicado: (2019)

Human endogenous retroviruses: ammunition for myeloid cells in neurodegenerative diseases?
por: Gruchot, Joel, et al.
Publicado: (2019)

Star power: harnessing the reactive astrocyte response to promote remyelination in multiple sclerosis
por: Junior, Markley Silva Oliveira, et al.
Publicado: (2023)

Identification of novel myelin repair drugs by modulation of oligodendroglial differentiation competence
por: Manousi, Anastasia, et al.
Publicado: (2021)

CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation
por: Kremer, David, et al.
Publicado: (2016)

Teriflunomide as a therapeutic means for myelin repair
por: Göttle, Peter, et al.
Publicado: (2023)

Remyelination In Multiple Sclerosis
por: Chari, Divya M.
Publicado: (2007)

Cryptococcal meningoencephalitis in an IgG(2)-deficient patient with multiple sclerosis on fingolimod therapy for more than five years – case report
por: Wienemann, Tobias, et al.
Publicado: (2020)

Remyelination Therapy in Multiple Sclerosis
por: Harlow, Danielle E., et al.
Publicado: (2015)

Promoting remyelination in multiple sclerosis
por: Cunniffe, Nick, et al.
Publicado: (2019)

Mesenchymal Stem Cell Conditioning Promotes Rat Oligodendroglial Cell Maturation
por: Jadasz, Janusz Joachim, et al.
Publicado: (2013)

Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2022)

The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
por: Ben-Shalom, Ido, et al.
Publicado: (2021)

Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
por: Podbielska, Maria, et al.
Publicado: (2013)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Jolanda Münzel, E., et al.
Publicado: (2013)

Imaging outcomes for trials of remyelination in multiple sclerosis
por: Mallik, Shahrukh, et al.
Publicado: (2014)

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis
por: You, Yuyi, et al.
Publicado: (2018)

Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
por: Correale, Jorge, et al.
Publicado: (2022)

Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model
por: Leo, Heinig, et al.
Publicado: (2022)

Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis
por: Zhao, Xinda, et al.
Publicado: (2023)

A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage
por: Werner, Luisa, et al.
Publicado: (2023)

Aberrant Oligodendrogenesis in Down Syndrome: Shift in Gliogenesis?
por: Reiche, Laura, et al.
Publicado: (2019)

Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure
por: Scalabrino, Giuseppe
Publicado: (2022)

Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal
por: Koska, Valeria, et al.
Publicado: (2021)

Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis
por: Brown, Robert A., et al.
Publicado: (2014)

Erratum to: Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Münzel, E. Jolanda, et al.
Publicado: (2013)

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis
por: Bodini, Benedetta, et al.
Publicado: (2016)

Remyelination in multiple sclerosis from the miRNA perspective
por: Maciak, Karina, et al.
Publicado: (2023)

Myelin repair is fostered by the corticosteroid medrysone specifically acting on astroglial subpopulations
por: Silva Oliveira Junior, Markley, et al.
Publicado: (2022)

Remyelination varies between and within lesions in multiple sclerosis following bexarotene
por: Brown, J. William L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k56e5gh5d4flqo3lvpmpase4sl